The -Omics in drug development
Moridani, Majid Y., Araujo, Robyn P., Johnson, Caroline H., & Lindon, John C. (2011) The -Omics in drug development. In Bonate, P.L. & Howard, D.R (Eds.) Pharmacokinetics in Drug Development : Volume 3 : Advances and Applications. Springer, pp. 145-173.
New advancement in genomics, proteomics, and metabonomics created significant excitement about the use of these relatively new technologies in drug design, discovery, development, and molecular-targeted therapeutics by identifying new drug targets and better tools for safety and efficacy studies in preclinical and clinical stages of drug development as well as diagnostics. In this chapter, we will briefly discuss the application of genomics, proteomics, and metabonomics in drug discovery and development
Impact and interest:
Citation counts are sourced monthly from and citation databases.
These databases contain citations from different subsets of available publications and different time periods and thus the citation count from each is usually different. Some works are not in either database and no count is displayed. Scopus includes citations from articles published in 1996 onwards, and Web of Science® generally from 1980 onwards.
Citations counts from theindexing service can be viewed at the linked Google Scholar™ search.
Repository Staff Only: item control page